Henshall et al. (2001) reported that AR expression in tumor epithelium and stroma that is associated with a poor clinical outcome in prostate cancer, on the other hand, AR is emerging as a potential new therapeutic target for the treatment of breast cancer (Giovannelli et al., 2018). This evidence concerns the gene AR and neoplasm.